These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 33328049)

  • 21. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Phys Ther; 2016 Jul; 96(7):e1-e10. PubMed ID: 27371692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
    Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
    BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of study reporting guidelines for clinical studies using artificial intelligence in healthcare.
    Shelmerdine SC; Arthurs OJ; Denniston A; Sebire NJ
    BMJ Health Care Inform; 2021 Aug; 28(1):. PubMed ID: 34426417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.
    Kendall TJ; Robinson M; Brierley DJ; Lim SJ; O'Connor DJ; Shaaban AM; Lewis I; Chan AW; Harrison DJ;
    Lancet Oncol; 2021 Oct; 22(10):e435-e445. PubMed ID: 34592193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Elbourne D; Juszczak E; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Chan AW; Montgomery AA
    JAMA Netw Open; 2023 Dec; 6(12):e2346121. PubMed ID: 38051535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI.
    Vasey B; Nagendran M; Campbell B; Clifton DA; Collins GS; Denaxas S; Denniston AK; Faes L; Geerts B; Ibrahim M; Liu X; Mateen BA; Mathur P; McCradden MD; Morgan L; Ordish J; Rogers C; Saria S; Ting DSW; Watkinson P; Weber W; Wheatstone P; McCulloch P;
    Nat Med; 2022 May; 28(5):924-933. PubMed ID: 35585198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
    Orkin AM; Gill PJ; Ghersi D; Campbell L; Sugarman J; Emsley R; Steg PG; Weijer C; Simes J; Rombey T; Williams HC; Wittes J; Moher D; Richards DP; Kasamon Y; Getz K; Hopewell S; Dickersin K; Wu T; Ayala AP; Schulz KF; Calleja S; Boutron I; Ross JS; Golub RM; Khan KM; Mulrow C; Siegfried N; Heber J; Lee N; Kearney PR; Wanyenze RK; Hróbjartsson A; Williams R; Bhandari N; Jüni P; Chan AW;
    JAMA; 2021 Jul; 326(3):257-265. PubMed ID: 34152382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE).
    McCarthy M; O'Keeffe L; Williamson PR; Sydes MR; Farrin A; Lugg-Widger F; Davies G; Avery K; Chan AW; Kwakkenbos L; Thombs BD; Watkins A; Hemkens LG; Gale C; Zwarenstein M; Langan SM; Thabane L; Juszczak E; Moher D; Kearney PM
    HRB Open Res; 2021; 4():82. PubMed ID: 34877471
    [No Abstract]   [Full Text] [Related]  

  • 32. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.
    Speich B; Mann E; Schönenberger CM; Mellor K; Griessbach AN; Dhiman P; Gandhi P; Lohner S; Agarwal A; Odutayo A; Puebla I; Clark A; Chan AW; Schlussel MM; Ravaud P; Moher D; Briel M; Boutron I; Schroter S; Hopewell S
    JAMA Netw Open; 2023 Jun; 6(6):e2317651. PubMed ID: 37294569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPIRIT 2013 statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krleža-Jerić K; Hróbjartsson A; Mann H; Dickersin K; Berlin JA; Doré CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Ann Intern Med; 2013 Feb; 158(3):200-7. PubMed ID: 23295957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI).
    Elvidge J; Hawksworth C; Avşar TS; Zemplenyi A; Chalkidou A; Petrou S; Petykó Z; Srivastava D; Chandra G; Delaye J; Denniston A; Gomes M; Knies S; Nousios P; Siirtola P; Wang J; Dawoud D;
    Value Health; 2024 Sep; 27(9):1196-1205. PubMed ID: 38795956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raising the Bar for Randomized Trials Involving Artificial Intelligence: The SPIRIT-Artificial Intelligence and CONSORT-Artificial Intelligence Guidelines.
    Taylor M; Liu X; Denniston A; Esteva A; Ko J; Daneshjou R; Chan AW;
    J Invest Dermatol; 2021 Sep; 141(9):2109-2111. PubMed ID: 33766511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
    Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Am J Occup Ther; 2016; 70(4):7004320010p1-11. PubMed ID: 27294998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krle A-Jerić K; Hrobjartsson A; Mann H; Dickersin K; Berlin JA; Dore CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Rev Panam Salud Publica; 2015 Dec; 38(6):506-14. PubMed ID: 27440100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.